LexShares is a litigation finance platform that provides non-recourse funding ranging from $200,000 to over $5 million for legal claims, allowing plaintiffs and law firms to pursue their cases without the risk of repayment if they lose. By offering strategic capital, LexShares enables clients to manage legal costs effectively and optimize their chances of achieving favorable outcomes in litigation.
Funding
Funding not disclosed
Founders
Product
Problem
Plaintiffs and law firms often face financial constraints when pursuing legal claims, limiting their ability to cover legal costs and potentially forcing them to settle for less than the full value of their case. Traditional funding options may be unavailable or come with recourse, placing additional financial risk on the litigant.
Solution
LexShares provides non-recourse litigation finance, enabling plaintiffs and law firms to pursue legal claims without the burden of upfront costs or the risk of repayment if the case is unsuccessful. By offering funding ranging from $200,000 to over $5 million, LexShares allows clients to manage legal expenses effectively and optimize their chances of achieving favorable outcomes. This strategic capital empowers litigants to stay the course, explore alternative fee arrangements, and avoid settling for less than their claim merits. LexShares' process involves an initial review of the legal claim, followed by a claims assessment and, upon approval, swift funding.
Target Audience
LexShares primarily serves corporate plaintiffs, attorneys, and law firms seeking non-recourse funding to pursue legal claims.
Features
- Non-recourse funding, eliminating the obligation to repay if the case is lost
- Funding amounts ranging from $200,000 to over $5 million for single cases and portfolios
- Efficient initial review process providing feedback on legal claims
- Claims assessment involving review of engagement agreements, damages analysis, and projected litigation budgets
- Funding for various case types, including breach of contract, theft of trade secrets, and fraud